Since PAK1 is a downstream effector for RAC3 and activating PAK1 variants cause NDD,45 dysregulation of this kinase is most likely to be involved in the pathogenesis of RAC3 variants. This evidence concerns the gene PAK1 and Neurodevelopmental delay.